Case report: Implantable cardioverter-defibrillator implantation with optimal medical treatment for lethal ventricular arrhythmia caused by recurrent coronary artery spasm due to tyrosine kinase inhibitors

Case report: Implantable cardioverter-defibrillator implantation with optimal medical treatment for lethal ventricular arrhythmia caused by recurrent coronary artery spasm due to tyrosine kinase inhibitors

Coronary artery spasm (CAS) may induce lethal ventricular arrhythmia due to severe and prolonged vessel constriction. Tyrosine kinase inhibitors are associated with the occurrence of CAS. Optimal medical treatment is the first-line therapeutic option for the management of CAS, whereas patients who e...

Full description

Bibliographic Details
Main Authors: Jifu Jin, Guang Xia, Yu Luo, Ying Cai, Ying Huang, Zhiyun Yang, Qinghui Yang, Bing Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
coronary artery spasm
tyrosine kinase inhibitors
ventricular arrhythmia
sudden cardiac death
implantable cardioverter-defibrillator
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1145075/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2023.1145075/full

Similar Items